EP 0495721 B1 19950628 - Use of a polypeptide having human interleukin-2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax.
Title (en)
Use of a polypeptide having human interleukin-2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax.
Title (de)
Verwendung eines Polypeptids mit humaner Interleukin-2 Aktivität zur Herstellung pharmazeutischer Zusammensetzungen zur Behandlung von Pneumothoraxen.
Title (fr)
Utilisation d'un polypeptide ayant l'activité de l'interleukine 2 humaine pour la préparation de compositions pharmaceutiques destinées au traitement des pneumothorax.
Publication
Application
Priority
FR 9100488 A 19910117
Abstract (en)
[origin: EP0495721A1] The subject of the invention is the use of a polypeptide having human interleukin-2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/20 (2006.01); A61P 11/00 (2006.01)
CPC (source: EP KR)
A61K 38/20 (2013.01 - KR); A61K 38/2013 (2013.01 - EP); A61P 11/00 (2017.12 - EP)
Designated contracting state (EPC)
AT BE CH DE DK FR GB IT LI LU NL PT SE
DOCDB simple family (publication)
EP 0495721 A1 19920722; EP 0495721 B1 19950628; AT E124264 T1 19950715; AU 1022192 A 19920723; AU 645653 B2 19940120; CA 2059512 A1 19920718; DE 69203098 D1 19950803; DE 69203098 T2 19951123; DK 0495721 T3 19951030; FR 2671728 A1 19920724; FR 2671728 B1 19950120; HU 207228 B 19930329; HU 9200147 D0 19920428; HU T60145 A 19920828; JP 3481954 B2 20031222; JP H0558907 A 19930309; KR 100216005 B1 19990816; KR 920014480 A 19920825; OA 09530 A 19921115; ZA 919682 B 19930224
DOCDB simple family (application)
EP 92400115 A 19920116; AT 92400115 T 19920116; AU 1022192 A 19920115; CA 2059512 A 19920116; DE 69203098 T 19920116; DK 92400115 T 19920116; FR 9100488 A 19910117; HU 9200147 A 19920116; JP 2582692 A 19920117; KR 920000557 A 19920116; OA 60128 A 19920117; ZA 919682 A 19911209